Literature DB >> 26970262

Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.

Giorgio Peretti1, Cesare Piazza2, Sara Penco1, Gregorio Santori3, Francesca Del Bon2, Sabrina Garofolo1, Alberto Paderno2, Luca Guastini1, Piero Nicolai2.   

Abstract

BACKGROUND: T3 laryngeal cancer encompasses heterogeneous lesions whose treatment is still debated. The purpose of this study was to evaluate transoral laser microsurgery (TLM) in management of selected T3 glottic and supraglottic cancers.
METHODS: Fifty-six patients with selected T3 glottic and supraglottic squamous cell carcinomas (SCCs) treated by TLM ± selective neck dissection ± adjuvant therapy were evaluated in terms of overall survival (OS), disease-free survival (DFS), and organ preservation rates.
RESULTS: For the entire cohort, 5-year OS and DFS were 63.3% and 72.4%, whereas they were 65.2% and 72.9% for glottic and 59.3% and 76.3% for supraglottic SCC, respectively. No patient required permanent tracheostomy and 1 patient was gastrostomy tube-dependent at last follow-up.
CONCLUSION: TLM ± selective neck dissection ± adjuvant (chemo)radiotherapy for selected T3 glottic and supraglottic SCC represents an effective alternative treatment to open partial laryngectomies and nonsurgical organ preservation protocols, particularly in elderly and frail patients.
© 2016 Wiley Periodicals, Inc. Head Neck 38: 1107-1112, 2016. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  T3 category; glottic cancer; oncologic outcomes; supraglottic cancer; transoral laser microsurgery

Mesh:

Year:  2016        PMID: 26970262     DOI: 10.1002/hed.24424

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

1.  Leveraging patient-reported outcomes data to inform oncology clinical decision making: Introducing the FACE-Q Head and Neck Cancer Module.

Authors:  Jennifer R Cracchiolo; Anne F Klassen; Danny A Young-Afat; Claudia R Albornoz; Stefan J Cano; Snehal G Patel; Andrea L Pusic; Evan Matros
Journal:  Cancer       Date:  2018-11-30       Impact factor: 6.860

2.  Role of imaging in the follow-up of T2-T3 glottic cancer treated by transoral laser microsurgery.

Authors:  Filippo Marchi; Cesare Piazza; Marco Ravanelli; Giovanna Gaggero; Giampiero Parrinello; Alberto Paderno; Pietro Perotti; Marta Filauro; Roberto Maroldi; Giorgio Peretti
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-19       Impact factor: 2.503

Review 3.  Conservative treatment for advanced T3-T4 laryngeal cancer: meta-analysis of key oncological outcomes.

Authors:  Giuditta Mannelli; Maria Silvia Lazio; Paolo Luparello; Oreste Gallo
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-08       Impact factor: 2.503

4.  Open partial horizontal laryngectomy for T2-T3-T4a laryngeal cancer: oncological outcomes and prognostic factors of two Italian hospitals.

Authors:  Marco de Vincentiis; Antonio Greco; Flaminia Campo; Francesca Candelori; Massimo Ralli; Mario Di Traglia; Andrea Colizza; Francesca Cambria; Jacopo Zocchi; Valentina Manciocco; Giuseppe Spriano; Raul Pellini
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-03       Impact factor: 2.503

5.  Impact of stage, management and recurrence on survival rates in laryngeal cancer.

Authors:  Jesper Brandstorp-Boesen; Ragnhild Sørum Falk; Morten Boysen; Kjell Brøndbo
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

6.  CO2 Transoral Microsurgery for Supraglottic Squamous Cell Carcinoma.

Authors:  Filippo Carta; Cinzia Mariani; Giovanni B Sambiagio; Natalia Chuchueva; Elisa Lecis; Clara Gerosa; Roberto Puxeddu
Journal:  Front Oncol       Date:  2018-09-04       Impact factor: 6.244

Review 7.  Limitations and Opportunities in Open Laryngeal Organ Preservation Surgery: Current Role of OPHLs.

Authors:  Giovanni Succo; Erika Crosetti
Journal:  Front Oncol       Date:  2019-05-22       Impact factor: 6.244

8.  Outcomes of Laryngeal Cancer Surgery after Open Partial Horizontal Laryngectomies with Lateral Cervical Approach.

Authors:  Andrea Colizza; Massimo Ralli; Arianna Di Stadio; Francesca Cambria; Federica Zoccali; Fabrizio Cialente; Diletta Angeletti; Antonio Greco; Marco de Vincentiis
Journal:  J Clin Med       Date:  2022-08-14       Impact factor: 4.964

9.  Comparison of Treatment Outcomes for T3 Glottic Squamous Cell Carcinoma: A Meta-Analysis.

Authors:  Bo Hae Kim; Sung Joon Park; Woo-Jin Jeong; Soon-Hyun Ahn
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-02-22       Impact factor: 3.372

10.  Three-Dimensional Map of Isoprognostic Zones in Glottic Cancer Treated by Transoral Laser Microsurgery as a Unimodal Treatment Strategy.

Authors:  Cesare Piazza; Marta Filauro; Alberto Paderno; Filippo Marchi; Pietro Perotti; Riccardo Morello; Stefano Taboni; Giampiero Parrinello; Fabiola Incandela; Andrea Iandelli; Francesco Missale; Giorgio Peretti
Journal:  Front Oncol       Date:  2018-05-22       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.